| Bioactivity | GLP-26 is a HBV capsid assembly modulators (CAM), inhibits HBV DNA replication in Hep AD38 system (IC50=3 nM), and reduces cccDNA by >90% at 1 μM.GLP-26 disrupts the encapsidation of pre-genomic RNA, causes nucleocapsid disassembly and reduces cccDNA pools[1]. | ||||||||||||
| Invitro | GLP-26 (0.7-1.7 μM; 3 days) reduces secreted HBeAg in HepNTCP-DL cells transfected with HBVwild type, with EC50 values of 0.7 μM[2]. Cell Viability Assay[2] Cell Line: | ||||||||||||
| Name | GLP-26 | ||||||||||||
| CAS | 2133017-36-2 | ||||||||||||
| Formula | C19H17F2N3O3 | ||||||||||||
| Molar Mass | 373.35 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Nijampatnam B, et al. Recent advances in the development of HBV capsid assembly modulators. Curr Opin Chem Biol. 2019 Jun;50:73-79. |
GLP-26
CAS: 2133017-36-2 F: C19H17F2N3O3 W: 373.35
GLP-26 is a HBV capsid assembly modulators (CAM), inhibits HBV DNA replication in Hep AD38 system (IC50=3 nM), and reduc
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.